Related Experiment Video
Updated: May 29, 2026

A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse
Published on: October 24, 2017
Automating first-trimester placenta volume measurements in three-dimensional ultrasonography using virtual reality
W A P Bastiaansen1, E S de Vos2, A H Koning3
1Department of Obstetrics and Gynecology, Erasmus MC, Rotterdam, Netherlands; Biomedical Imaging Group Rotterdam,Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands.
Introduction:
Volumetric measurements of the placenta in the first trimester provide insights into placental development and early markers for placenta-related complications. Current manual placental volume (PV) measurement using Virtual Organ Computer-Aided Analysis (VOCAL) on three-dimensional (3D) ultrasound is time-consuming and limited to two-dimensional (2D) planes. We aimed to validate a Virtual Reality (VR)-based 3D PV measurement and develop an automated Artificial Intelligence (AI) method for PV measurement.
Methods:
3D ultrasound images from 83 singleton pregnancies (115 images) at 7, 9, and 11 weeks gestation from the Rotterdam Periconception Cohort were analyzed. A validation set of 414 paired images was added to assess AI-PV reproducibility using two sequential 3D ultrasounds. VOCAL-PV involved manual tracing at 15° intervals in 2D planes. VR-PV used an in-house VR system for manual voxel selection in 3D. AI-PV used nnU-Net trained on VR-PV. Absolute error, Dice scores, and measurement time were compared.
Results:
VR-PV showed average absolute errors of 2.0 cm3 (week 7), 4.4 cm3 (week 9), and 7.6 cm3 (week 11). AI-PV had similar errors respectively: 2.2 cm3, 4.5 cm3, and 9.2 cm3. Dice overlap between AI-PV and VR-PV was 79-82%. AI-PV reproducibility errors were respectively 0.7 cm3, 1.2 cm3, and 1.2 cm3. AI-PV measurement time was 1 min versus 11 min for VOCAL and VR.
Discussion:
VR-PV and AI-PV enable accurate first-trimester PV measurement. AI-PV eliminates manual input, reduces time, and supports scalable PV assessment for research and early clinical screening, with potential to improve early detection and management of placenta-related complications.

